PrEP RESEARCH ARTICLES/COMMENTARY

Are we prepped for PrEP? Provider opinions on the real-world use of PrEP in the U.S. and Canada, Clinical Infectious Diseases, December 2013
Adherence to Antiretroviral Prophylaxis for HIV Prevention: A Substudy Cohort within a Clinical Trial of Serodiscordant Couples in East Africa, PLoS Medicine, September 2013
Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges, PNAS, September 2013
How Acceptable are ARVs for the Prevention of Sexually Transmitted HIV?: A Review of Research on the Acceptability of Oral PrEP and TasP, AIDS and Behavior, July 2013
PrEP for HIV infection in injecting drug users in Bangkok, Thailand: a randomised, double-blind, placebo-controlled phase 3 trial, The Lancet, June 2013

CURE-BASED RESEARCH ARTICLES/COMMENTARY

Targeted Cytotoxic Therapy Kills Persisting HIV Infected Cells During ART, PLoS Pathogens, January 9, 2014
HIV Cure: The Target is Clearer but Not Yet Close, Dr. Paul Volberding, Annals of Internal Medicine, January 2014
Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure, Cell, October 2013
Effect of HIV Therapy on Reservoirs in Elite Controllers, Journal of Infectious Diseases, July 2013
A cure for HIV: where we’ve been, and where we’re headed, The Lancet, June 2013
30 years of HIV: Long road ahead to a cure, HIVandHepatitis, June 2013
No, HIV is NOT about to be cured in three months, Project Inform, May 2013
Three Types of HIV Cure, amfAR, April 2013
Exciting data on early HIV treatment, but media too quickly calling it a “Cure”, Project Inform, March 2013
CROI Report 2013: Observations on the “Cure Agenda”, by David Margolis MD, UNC Chapel Hill and the Collaboratory of AIDS Researchers for Eradication (CARE), March 2013
Post-treatment HIV-1 controllers with a long-term virological remission after interruption of early therapy, ANRS VISCONTI Study, PLoS Pathogens, March 2013
Pegylated interferon monotherapy suppresses HIV replication and decreased cell-associated HIV DNA integration, Journal of Infectious Disease, January 2013
Brief interruption of HIV therapy in patients with preserved CD4 count and virologic suppression is safe and well tolerated, IDSA San Diego, October 2012
Targeted gene knockout by direct delivery of zinc-finger nuclease proteins, Nature Methods, July 2012
HIV reservoirs: Pathogenesis and obstacles to viral eradication and cure, AIDS, March 2012
New HIV Cure Research Findings: Radioimmunotherapy Therapy, PLoS One, March 2012
Impact of multi-targeted treatment on gut T cell depletion and HIV reservoir seeding during acute infection, PLoS One, March 2012
Tim Brown and Matt Sharp’s Quest for a Cure of HIV, November 2011

Resources:
SearcHIV Working Group, UNC (Chapel Hill, NC): website, blog, twitter

HIV & AGING RESEARCH AND RESOURCES

Study results/commentary:
A dedicated clinic for HIV-positive individuals over 50 years of age: a multidisciplinary experience, International Journal of STD & AIDS, re-published June 2013
‘People Think It’s Over’: Spared death, aging people with HIV struggle to live, The New York Times, June 1, 2013
The Immune System, HIV and Aging, Treatment Action Group, June 2013
Aging with HIV: Where do we stand after CROI 2013?, David Wohl MD, May 2013
Management of HIV infection in advanced age, JAMA, April 2013
Mortality in well controlled HIV in the continuous therapy arms of SMART and ESPRIT trials compared to general population, AIDS, March 2013
Older HIV+ patients on HIV therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction, AIDS, January 2013
Non-AIDS Illness Rate Higher in Older HIV-Positives Than in Similar non-HIV Group, Marc Mascolini, July 2012, XIX International AIDS Conference

Resources:
LGBT Task Force on Aging (San Francisco), Marcy Adelman, AARP, 415-285-4307
ACRIA’s Center on HIV & Aging, ACRIA Google group
Anal Cancer Resource Center, UCSF
Aging with HIV Resource Center, TheBody.com

OTHER HIV CARE RESEARCH/COMMENTARY

People doing well on HIV therapy have a mortality risk identical to that of HIV-negative peers, AIDSmap, June 2013
Undetectable is not always enough, Treatment Action Group, May 2013